DAB2IP and central nervous system cancer: For instance, DAB2IP deficiency was found to upregulate Wnt‐mediated NLGN3 secretion, which in turn transformed neighboring glioma cells into cancer stem cells (CSCs) and contributed to tumor aggressiveness [44].